[ad_1] German biotech company CureVac has announced that its experimental vaccine developed against the COVID-19 disease has the ability to remain stable at 5 degrees Celsius for at least three months, making it easier to transport than vaccines created by other rivals in the world. pharmaceutical industry, informs Reuters. CureVac, …
Read More »CureVac Germans Strike Out Rivals: Their COVID-19 Vaccine Can Be Transported In Regular Refrigerated Containers – Source News
